Reactions Weekly

, Volume 1697, Issue 1, pp 306–306 | Cite as

Ombitasvir/paritaprevir/ritonavir

Hyperkalaemia: case report
Case report
  • 12 Downloads

Reference

  1. Suda G, et al. Safety and efficacy of paritaprevir/r and ombitasvir combination therapy for HCV infected patients with Cryoglobulinemia. Hepatology International 12: S492-S493, No. 2, Jan 2018. Available from: URL: http://doi.org/10.1007/s12072-018-9852-3 [abstract] - JapanGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations